DA Arrears Calculator 1.7.2024 for 3 MonthsRevision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules
CGHS Reimbursement: Ceiling Rates Cardiac Devices
Government of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare
Directorate Genera! of CGHS
Office of the Director, CGHS
No. S-11011/29/2018-CGHS(HEC)/ DIR/CGHS
Nirman Bhawan, New Delhi
Dated the 6th August, 2018
Office Memorandum
Subject:- Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules
With reference to the above subject attention is drawn to the OM No 12034/02/2014/Misc./CGHS D.III dated 22nd July 2014 vide which ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS (MA) Rules were prescribed and to state that the matter has been reviewed by the Ministry and it is decided to revise the ceiling rates as per the details given under:
| 1 | Single Chamber Cardiac Pacemaker without rate response – | Rs.34,840/- + GST |
|---|---|---|
| 2 | Single Chamber Cardiac Pacemaker with rate respose | Rs.44,928/- + GST |
| 3 | Daul Chambers Cardiac Pacemaker | Rs.83,200/- + GST |
| 4 | Bi-Ventricular Pacemaker (CRT-P) | Rs.1,95,000/- + GST |
| 5 | Implantable Cardioverter Defibrillator (Single Camber) (ICD/AICD-Single Chamber) | Rs. 1,75,786/- + GST |
| 6 | Implantable Cardioverter Defibrillator (Daul Camber) (ICD/AICD-Daul Chamber) | Rs.3,75,000/- + GST |
| 7 | Combo Device (CRT-D) | Rs.4,90,000/- + GST |
| 8 | Aortic Stent Graft (expandable bifurcated and including delivery system) | Rs.4,40,960/- + GST |
| 9 | Rotablator with advance | Rs.49,920/- + GST |
| 10 | Rotablator Burr | Rs.23,920/- + GST |
2. Other terms and conditions prescribed under OM No 12034/02/2014/Misc./-CGHS D.III dated 22nd July 2014 shall remain unchanged.
3. These rates shall remain valid till the rates for the above devices are notified by National Pharmaceutical Pricing Authority (NPPA).
4. Issued with the concurrence of SS&FA, Ministry of Health & Family Welfare vide CD — 1295 dated 25.07.2018.
sd/-
Dr. Atul Prakash)
Director, CGHS
Leave a Reply